Overall Fundamental outlook

Business Operations:

Sector: Basic Materials
Industry: Specialty Chemicals

Clean Science and Technology Limited, research, develops, manufactures, and markets specialty chemicals in India and internationally. The company operates through Performance Chemicals, FMCG Chemicals, and Pharma & Agro Intermediates segments. It also offers FMCG Chemicals, including anisole, guaiacol, 4-methoxy acetophenone, butylated hydroxy anisole, veratrole, L-ascorbyl palmitate, tertiary butyl hydroquinone, ortho methoxy toluene, and para di-methoxy benzene (1,4-DMB). In addition, the company offers performance chemicals comprising clean light stab 770, 4-hydroxy tempo, mono methyl ether of hydroquinone, butylated hydroxy anisole, L-ascorbyl palmitate, 2,5-di-tertiary butyl hydroquinone, tertiary butyl hydroquinone, and dimethyl sebacate. Further, it provides pharma and agro intermediates, such as dicyclohexylcarbodimide, veratrole, para benzoquinone, and para di-methoxy benzene (1,4-DMB). Clean Science and Technology Limited serves food and infant food formulations, agricultural chemicals, polymers and monomers, perfumes, cosmetic, and other sectors. The company was incorporated in 2003 and is based in Pune, India.

Revenue projections:

Revenue projections for CLEAN
Revenue projections for CLEAN

Investors are expected to be cautious with CLEAN, as its revenues are projected to fall compared to last year. A decline in revenue often results in a negative impact on profitability, prompting concerns about the company's financial stability and making investors more conservative in their approach.

Financial Ratios:

currentRatio 0.000000
forwardPE 30.438986
debtToEquity 0.150000
earningsGrowth 0.063000
revenueGrowth 0.084000
grossMargins 0.637660
operatingMargins 0.334310
trailingEps 25.300000
forwardEps 35.090000

CLEAN's positive gross and operating margins suggest strong profitability. These margins reflect effective cost management and revenue generation, indicating that the company is efficiently managing its operations and maintaining financial health.
Clean Science and Technology Limited's forward EPS being higher than its trailing EPS points to expected growth in profitability. This suggests that the company is projected to perform better in the current financial year, with higher earnings forecasted compared to the previous year.

Price projections:

Price projections for CLEAN
Price projections for CLEAN

CLEAN's stock price has consistently been near the lower edge of expected values, indicating potential struggles in meeting growth projections. This trend may reflect a cautious market sentiment toward the company.

Recommendation changes over time:

Recommendations trend for CLEAN
Recommendations trend for CLEAN


Clean Science and Technology Limited has been receiving a buy bias from analysts, indicating confidence in its investment potential. This could drive more investors to view Clean Science and Technology Limited as a reliable choice for their money, offering a promising avenue for future growth and financial gains.